No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: Potential explanations

Ishwarlal Jialal, Sandeep Dhindsa

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)157-158
Number of pages2
JournalMetabolic Syndrome and Related Disorders
Volume12
Issue number3
DOIs
StatePublished - Apr 1 2014

Fingerprint

Adamantane
Dipeptidyl-Peptidase IV Inhibitors
Diabetic Angiopathies
Dipeptides
Hypoglycemic Agents
Type 2 Diabetes Mellitus
saxagliptin

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus : Potential explanations. / Jialal, Ishwarlal; Dhindsa, Sandeep.

In: Metabolic Syndrome and Related Disorders, Vol. 12, No. 3, 01.04.2014, p. 157-158.

Research output: Contribution to journalArticle

@article{c503be34af614d9aaefb646f11b4077e,
title = "No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus: Potential explanations",
author = "Ishwarlal Jialal and Sandeep Dhindsa",
year = "2014",
month = "4",
day = "1",
doi = "10.1089/met.2014.1500",
language = "English (US)",
volume = "12",
pages = "157--158",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - No benefit of saxagliptin on cardiovascular outcomes in type 2 diabetes mellitus

T2 - Potential explanations

AU - Jialal, Ishwarlal

AU - Dhindsa, Sandeep

PY - 2014/4/1

Y1 - 2014/4/1

UR - http://www.scopus.com/inward/record.url?scp=84896979721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896979721&partnerID=8YFLogxK

U2 - 10.1089/met.2014.1500

DO - 10.1089/met.2014.1500

M3 - Article

C2 - 24520851

AN - SCOPUS:84896979721

VL - 12

SP - 157

EP - 158

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 3

ER -